Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

REGENXBIO Inc.

CIK 1590877Updated Nov 16, 2026

Name history
ReGenX Biosciences, LLC · through Nov 7, 2013

RGNX price & chart

Provider market data

Loading TradingView…

NASDAQ:RGNX on TradingView ↗

TradingView · Data may be delayed

About the company

REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie, and RGX-121 (clemidsogene lanparvovec) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA® and ITVISMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit www. REGENXBIO.com.

8-K · 2026-11-05 · 0001193125-26-448559

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue170,441,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

Net income-193,878,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

Operating income-161,198,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

Diluted EPS-3.76USD per share · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD525,203,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

519,114,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

386,618,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

581,027,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

569,379,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

341,894,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

490,929,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

629,215,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

453,032,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

465,989,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

573,970,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

833,268,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Property, Plant and Equipment, NetUSD107,515,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

120,551,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

98,452,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

111,017,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

123,969,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

101,874,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

114,497,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

127,662,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

104,855,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

117,589,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

132,103,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

141,685,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD58,802,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

56,617,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2024-09-30

36,487,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

79,558,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2025-06-30

57,765,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2024-06-30

15,229,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

130,104,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2025-03-31

112,975,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2024-03-31

34,466,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

57,526,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

34,522,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

96,952,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD25,347,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

23,604,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

106,754,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

20,199,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

22,809,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

10,038,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

18,192,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

15,828,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

26,379,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

20,473,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

24,790,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

28,082,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Assets, CurrentUSD331,967,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

313,396,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

236,157,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

373,752,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

346,683,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

186,516,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

313,237,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

395,418,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

281,281,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

278,001,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

334,971,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

415,976,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD48,820,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

55,293,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

43,867,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

50,469,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

56,344,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

45,541,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

52,112,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

57,558,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

47,156,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

53,716,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

60,487,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

65,116,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Other Assets, NoncurrentUSD4,268,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

4,332,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

5,902,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

1,879,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

2,946,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

5,513,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

2,987,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

4,217,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

4,613,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

4,000,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

4,807,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

6,397,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD363,751,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

217,698,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

314,853,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

367,348,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

221,112,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

320,812,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

216,732,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

238,549,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

350,299,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

206,338,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

262,228,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

317,073,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD5,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

5,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

5,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

5,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

5,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

5,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

5,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

5,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

5,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

5,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

4,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

4,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-1,058,878,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

-880,963,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

-1,193,369,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

-996,937,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

-821,366,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

-1,216,078,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

-926,066,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

-768,377,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

-1,126,027,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

-932,149,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

-705,047,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

-441,553,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-652,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

-582,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

-875,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

-750,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

-2,266,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

-870,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

-762,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

-3,229,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

-687,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

-741,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

-4,429,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

-15,401,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD161,452,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

301,416,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2024-09-30

71,765,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

213,679,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2025-06-30

348,267,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2024-06-30

21,082,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

274,197,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2025-03-31

390,666,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2024-03-31

102,733,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

259,651,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

311,742,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

516,195,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Additional Paid in Capital, Common StockUSD1,220,977,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

1,182,956,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

1,266,004,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

1,211,361,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

1,171,894,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

1,238,025,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

1,201,020,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

1,162,267,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

1,229,442,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

1,192,536,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

1,021,214,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

973,145,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Liabilities and EquityUSD525,203,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

519,114,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

386,618,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

581,027,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

569,379,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

341,894,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

490,929,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

629,215,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

453,032,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

465,989,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

573,970,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

833,268,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD124,568,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

102,725,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

82,621,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

119,540,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

98,273,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

71,110,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

106,731,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

110,179,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

118,095,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

103,194,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

130,272,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

130,434,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Operating Lease, Liability, CurrentUSD9,073,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

7,720,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

7,355,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

8,049,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

7,302,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

7,867,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

7,942,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

7,066,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

8,286,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

7,902,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

7,068,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

5,997,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Accounts Payable, CurrentUSD22,266,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

19,522,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

15,546,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

21,655,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

16,362,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

21,207,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

19,044,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

31,356,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

21,358,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

22,798,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

22,786,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

27,213,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD67,433,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

76,342,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

61,596,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

69,647,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

78,234,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

63,199,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

71,906,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

80,183,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

65,215,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

74,131,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

82,222,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

88,802,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Other Liabilities, NoncurrentUSD648,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

3,579,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

486,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

664,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

3,526,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

622,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

680,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

3,485,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

638,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

3,635,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

6,249,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

8,832,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Additional Financial Items
Accounts Receivable, after Allowance for Credit LossUSD28,112,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

24,008,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2024-09-30

107,189,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

21,783,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2025-06-30

23,273,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2024-06-30

10,458,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

19,400,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2025-03-31

16,351,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2024-03-31

28,691,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

20,947,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

25,491,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

29,586,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD302,000,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

278,600,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

105,500,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

363,600,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

327,300,000
Source

10-Q · 2024-08-01 · 0000950170-24-089320

As of 2024-06-30

150,500,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

272,700,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

380,500,000
Source

10-Q · 2024-05-08 · 0000950170-24-055691

As of 2024-03-31

240,900,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

244,900,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

314,100,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

565,200,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-90,051,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

6,083,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-193,878,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-227,102,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-263,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,321,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

—
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————8,617,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

8,537,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

34,563,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

38,463,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

40,267,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

40,788,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————-18,249,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

-1,572,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

7,661,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-9,707,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-3,935,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-4,822,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-76,186,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

33,629,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-123,963,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-173,125,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-218,407,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-207,488,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————70,588,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

44,743,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-15,868,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

103,446,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

190,943,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-11,929,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————1,235,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

1,024,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

2,414,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

2,436,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

9,960,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

30,724,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————-13,639,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

-5,794,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

116,771,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

92,683,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-34,966,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-28,840,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-19,237,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

72,578,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-23,060,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

23,004,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-62,430,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-248,257,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——60,832,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

58,647,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2024-09-30

38,517,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

81,588,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2025-06-30

17,259,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

132,134,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2025-03-31

36,496,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

59,556,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

36,552,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

98,982,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD————————285,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-72,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-142,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

11,812,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——8,998,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

9,884,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

9,053,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

8,653,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

8,617,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

8,537,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

34,563,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

38,463,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

40,267,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

40,788,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD——302,000,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

As of 2025-09-30

278,600,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

As of 2024-09-30

105,500,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

As of 2026-06-30

363,600,000
Source

10-Q · 2025-08-07 · 0001193125-25-174953

As of 2025-06-30

150,500,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

As of 2026-03-31

272,700,000
Source

10-Q · 2025-05-12 · 0000950170-25-069237

As of 2025-03-31

240,900,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

As of 2025-12-31

244,900,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

As of 2024-12-31

314,100,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

As of 2023-12-31

565,200,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

As of 2022-12-31

Debt Securities, Available-for-sale, Realized Gain (Loss)USD——0
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

—0
Source

10-Q · 2025-08-07 · 0001193125-25-174953

2025-04-01 to 2025-06-30

0
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

———
Foreign Currency Transaction Gain (Loss), before TaxUSD————————-100,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-900,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Gain (Loss) on InvestmentsUSD———————————-79,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——20,253,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

19,422,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

21,616,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

19,883,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

21,306,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

20,347,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

82,863,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

76,619,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

88,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

85,281,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

—-152,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-84,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

InterestExpenseNonoperatingUSD——13,169,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

820,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

7,793,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

10,993,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

8,708,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

8,570,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

45,008,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

12,659,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Investment Income, InterestUSD——3,600,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

3,300,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

1,200,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

3,400,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

2,000,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

2,500,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

12,200,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

12,100,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Net Income (Loss) Attributable to ParentUSD——-61,941,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

-59,597,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

22,709,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-70,871,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-90,051,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

6,083,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-193,878,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-227,102,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-263,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,321,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——————————-263,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,321,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——-9,530,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

2,481,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

-6,554,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-7,593,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-6,689,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

-6,044,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-32,680,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

6,244,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

4,482,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-17,529,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD——————146,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

150,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

318,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

1,512,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

1,521,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

2,804,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Provision for Loan, Lease, and Other LossesUSD—————————-5,000,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Realized Investment Gains (Losses)USD————————62,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

6,616,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

2,205,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

—
Revenue from Contract with Customer, Including Assessed TaxUSD——29,733,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

24,197,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

108,019,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

21,359,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

6,393,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

89,012,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

170,441,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

———
LitigationSettlementLoss———————
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

—————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——29,733,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

24,197,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

108,019,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

21,359,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

6,393,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

89,012,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

170,441,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

83,328,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

90,242,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

112,724,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Cost of RevenueUSD———12,387,000
Source

10-Q · 2024-11-06 · 0000950170-24-122330

2024-07-01 to 2024-09-30

—————33,567,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

37,213,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

54,545,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Gross Profit (Calculated) · Derived————————————
Operating Income (Loss)USD——-52,411,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

-62,078,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

29,263,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-63,278,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-83,362,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

12,127,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-161,198,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-233,346,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-268,128,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-262,876,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD————————-193,878,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-227,102,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-263,646,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,405,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

—-152,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-84,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-61,941,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

-59,597,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

22,709,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-70,871,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-90,051,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

6,083,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-193,878,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-227,102,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-263,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,321,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-1.2
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

-1.17
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

0.43
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-1.38
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-1.72
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

0.12
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-3.76
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-4.59
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-6.02
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-6.5
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-1.2
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

-1.17
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

0.43
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-1.38
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-1.72
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

0.12
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-3.76
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-4.59
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-6.02
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-6.5
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——51,689,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

50,800,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

52,820,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

51,483,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

52,428,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

51,362,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

51,573,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

49,509,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

43,734,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

43,152,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——51,689,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

50,800,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

53,016,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

51,483,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

52,428,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

51,434,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

51,573,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

49,509,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

43,734,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

43,152,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD——13,169,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

820,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

7,793,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

10,993,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

8,708,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

8,570,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

45,008,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

12,659,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Additional Financial Items
Costs and ExpensesUSD——82,144,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

86,275,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

78,756,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

84,637,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

89,755,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

76,885,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

331,639,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

316,674,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

358,370,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

375,600,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Current Income Tax Expense (Benefit)USD——————————-152,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-84,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Depreciation, Depletion and Amortization, NonproductionUSD——————3,857,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

3,955,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

15,615,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

16,215,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

17,320,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

12,909,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), before TaxUSD————————-100,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-900,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Gain (Loss) on InvestmentsUSD———————————-79,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——20,253,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

19,422,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

21,616,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

19,883,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

21,306,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

20,347,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

82,863,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

76,619,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

88,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

85,281,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-193,795,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

-227,022,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

-263,574,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,341,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Interest ExpenseUSD——————————6,862,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

23,254,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——3,600,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

3,300,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

1,200,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

3,400,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

2,000,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

2,500,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

12,200,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

12,100,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

——
Investment Income, NetUSD——3,620,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

3,276,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

1,222,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

3,379,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

2,003,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

2,501,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

12,245,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

18,729,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

11,319,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

5,383,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——————————-263,494,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-280,321,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——-9,530,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

2,481,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

-6,554,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

-7,593,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

-6,689,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

-6,044,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

-32,680,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

6,244,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

4,482,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

-17,529,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Realized Investment Gains (Losses)USD————————62,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

6,616,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

2,205,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

—
Research and Development ExpenseUSD——56,101,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

54,429,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

56,086,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

59,500,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

57,339,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

53,087,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

228,299,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

208,522,000
Source

10-K · 2025-03-13 · 0000950170-25-038770

2024-01-01 to 2024-12-31

232,266,000
Source

10-K · 2024-02-27 · 0000950170-24-021161

2023-01-01 to 2023-12-31

242,453,000
Source

10-K · 2023-02-28 · 0000950170-23-005085

2022-01-01 to 2022-12-31

Revenue from Contract with Customer, Including Assessed TaxUSD——29,733,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2025-07-01 to 2025-09-30

24,197,000
Source

10-Q · 2025-11-06 · 0001193125-25-268095

2024-07-01 to 2024-09-30

108,019,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2026-04-01 to 2026-06-30

21,359,000
Source

10-Q · 2026-08-06 · 0001193125-26-336725

2025-04-01 to 2025-06-30

6,393,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

89,012,000
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2025-01-01 to 2025-03-31

170,441,000
Source

10-K · 2026-03-05 · 0001193125-26-094013

2025-01-01 to 2025-12-31

———
LitigationSettlementLoss———————
Source

10-Q · 2026-05-14 · 0001193125-26-222804

2026-01-01 to 2026-03-31

—————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

rgnx-ex99_1.htm · 8-K · 2026-11-05

EXHIBIT 99.1 REGENXBIO Reports Third Quarter 2026 Financial Results and Operational Highlights • RGX-202 BLA submission for Duchenne muscular dystrophy on track for Q1 2027, with potential accelerated approval in 2H 2027 • Topline data from pivotal subretinal wet AMD studies, ATMOSPHERE® and ASCENT®, expected in Q4 2026 • Phase IIb/III NAAVIGATE trial for diabetic retinopathy ongoing • Webcast today at 8:00 a.m. ET ROCKVILLE, Md., November 5, 2026 (PR Newswire) -- REGENXBIO Inc. (Nasdaq: R…

8-K · 2026-11-05 · 0001193125-26-448559

Read attachment ↗
rgnx-ex99_1.htm · 8-K · 2026-08-25

EX-99.1 2 rgnx-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli ROCKVILLE, Md., August 25, 2026 - REGENXBIO Inc. (Nasdaq: RGNX) today announced the appointment of Greg Ciongoli to its Board of Directors, effective August 25, 2026. With multiple upcoming catalysts across its late-stage pipeline of potential first-and best-in-class gene therapies, Mr. Ciongoli joins the Board as REGENXBIO prepares to become a global commercia…

8-K · 2026-08-25 · 0001193125-26-365287

Read attachment ↗
rgnx-ex99_1.htm · 8-K · 2026-08-24

EX-99.1 2 rgnx-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 REGENXBIO Announces Regulatory Update on RGX-121 for MPS II ROCKVILLE, Md., August 24, 2026 - REGENXBIO Inc. (Nasdaq: RGNX) today provided an update on its investigational gene therapy, RGX-121 (clemidsogene lanparvovec), for the treatment of Mucopolysaccharidosis type II (MPS II), also known as Hunter Syndrome. The U.S. Food and Drug Administration (FDA) placed a clinical hold on RGX-121 following the discovery of asymptomatic spine …

8-K · 2026-08-24 · 0001193125-26-363786

Read attachment ↗
rgnx-ex99_1.htm · 8-K · 2026-08-06

EX-99.1 2 rgnx-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights • RGX-202 BLA submission for Duchenne muscular dystrophy on track for Q3 2026 initiation, with potential accelerated approval in 2H 2027 • Long-term surabgene lomparvovec (sura-vec, ABBV-RGX-314) data highlight durable safety and efficacy profile ahead of key catalyst o Topline data from pivotal subretinal wet AMD studies, ATMOSPHERE® and ASCENT®, ex…

8-K · 2026-08-06 · 0001193125-26-336716

Read attachment ↗
d40931dex41.htm · 8-K · 2026-07-20

EX-4.1 3 d40931dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 REGENXBIO INC. FORM OF WARRANT TO PURCHASE COMMON STOCK Number of Shares: [•] (subject to adjustment) Warrant No. [•] Original Issue Date: July [__], 2026 ───────────────────────────────────────────────────────────── REGENXBIO Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [•] or its permitted registered ass…

8-K · 2026-07-20 · 0001193125-26-308342

Read attachment ↗
d40931dex991.htm · 8-K · 2026-07-20

EX-99.1 5 d40931dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants Jul 17, 2026 at 7:00 AM EDT ROCKVILLE, Md., July 17, 2026 /PRNewswire/ - REGENXBIO Inc. (Nasdaq: RGNX) today announced the pricing of an underwritten public offering of 10,003,889 shares of its common stock at the price of $9.00 per share and 1,111,111 pre-funded warrants at a price of $8.9999 per warrant, in each case before underwriting discount…

8-K · 2026-07-20 · 0001193125-26-308342

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.